Lodgkin lymphoma ya kasance daya daga cikin wadannan ciwon daji inda ba a fahimci sosai game da dalilin lymphoma ba. Abinda aka sani kawai wanda yake da mahimmanci shine kamuwa da cuta tare da Epstein Barr Virus (EBV). Amma binciken da aka wallafa a kwanan nan ya nuna cewa shan taba yana iya taka muhimmiyar rawa a hadarin Lymphoma na Hodgkin.
Bincike na Nemi Ƙarin Hodgkin Rashin Lafiya Lymphoma Daga cikin masu shan taba
Wani binciken da aka buga a cikin wata jarida a cikin Janairun 2007, ya nuna cewa shan taba yana iya zama abu ɗaya wanda ke haifar da ci gaba da lymphoma Hodgkin ko akalla ƙara yawan haɗarinsa.
A cikin binciken da aka yi a tsakanin masu fama da lymphoma Hodgkin da mutane masu lafiya, an kiyasta tasirin shan taba da shan barasa. Sakamakon ya zama abu mai ban sha'awa:
- Overall, masu shan taba suna da kasuwa 40% na haɓaka ƙwayar lymphoma Hodgkin.
- Rashin haɗari ya fi girma a cikin masu shan taba (masu shan taba a cikin shekaru biyu da suka gabata) fiye da wadanda suka bar shan taba. Rashin haɗari ya rage zuwa matakin daya kamar wadanda ba su taba shan taba ba game da shekaru 10 bayan sun bar. Wannan labari ne mai kyau ga 'yan gudun hijirar da kuma dalili da za su yi la'akari da haka idan kun kasance fataucin yau.
- Wadanda ke da lymphoma na Hodgkin da ke dauke da cutar Epstein Barr Virus (EBV) suna da alaka da haɗarin shan taba fiye da waɗanda wadanda lymphoma su ke cikin su ne EBV. Wannan yana nuna cewa shan taba da EBV zasu iya hulɗa don ƙara damar yin amfani da lymphoma Hodgkin. Ba mu san yadda wannan hulɗa zai faru ba. Amma mai smoker wanda ya san cewa sune tabbataccen EBV yana da mahimmanci don dakatar da shan taba.
- Akwai alama babu hanyar haɗi tsakanin abincin barasa da hadarin lymphoma na Hodgin. Wannan labari ne mai kyau ga wadanda suke jin dadin shan ko kaɗan.
Binciken Nazarin Bincike Ƙarin Rashin Ƙari ga Masu Shan Dubu
Binciken binciken tun daga shekarar 2007 ya ci gaba da samun karin haɗari tsakanin masu shan taba don Hodgkin lymphoma. Cibiyar Bincike ta Cancer Birtaniya ta ce kimanin kashi 10-15% ne mafi girma ga mutanen da suka taba shan taba idan aka kwatanta da mutanen da ba su taba taba taba ba.
Amma kamar yadda binciken binciken na 2007 ya yi, yawancin haɗari ne da mutanen da ke shan taba yanzu. Har ila yau, yana dogara ne - idan ka shan taba ƙari, haɗarinka ya hau, kuma idan ka shan taba kasa, ba kamar yadda aka daukaka ba. Ana iya ganin sakamako ga mafi girma daga maza, don haka jinsi yana da nauyin taka rawa. Har ila yau an fi sanin mazan da ka samu, wanda zai iya danganta da yawan shekarun da wani ke shan taba.
Bishara ita ce, ƙwayar lymphoma yara Hodgkin ba ta da haɗari idan uwar ta kyafaffen lokacin daukar ciki. Duk da yake akwai dalilai da dama da ya sa mace mai ciki ba za ta taba shan taba ba, ƙaddamar da hadarin Lymphoma na Hodgkin bai zama daya ba.
Wadannan sakamakon ƙara wani ciwon daji zuwa jerin jerin cututtuka masu shan taba. Idan kana shan taba, ga wani dalili na daina dakatar. Wataƙila ba a saman jerin dalilai ba, amma idan kana da iyaye, abokin ko dangi tare da Hodgkin yana iya zama dalilin da kake buƙatar ɗaukar mataki don zama abin ƙyama.
Sources:
Willett EV, O'Connor S, Smith AG, Roman E. Shin shan taba ko barasa ya canza haɗarin cutar kwayar cutar Epstein-Barr ko kuma lymphoma Hodgkin? Epidemiology. 2007; 18: 130-136.
Sergentanis TN, Kanavidis P, Michelakos T, et al. Cigarette shan taba da kuma hadarin lymphoma a cikin manya: cikakken nazarin meta-bincike game da Hodgkin da rashin Hodgkin cuta (link ne waje). Eur J Cancer Preva 2013; 22 (2): 131-50.
Kamper-Jørgensen M, Rostgaard K, Glaser SL, et al. Cigarette shan taba da kuma hadarin Hodgkin lymphoma da subtypes: wani shugabanci bincike daga International Lymphoma Epidemiology Consortium (InterLymph) (link ne waje). Ann Oncol 2013; 24 (9): 2245-55.
Castillo JJ, Dalia S, Shum H. Meta-bincike na ƙungiya tsakanin shan taba da kuma tasirin Hodgkin Lymphoma (haɗin ke waje). J Jara Incol. 2011; 29 (29): 3900-6.
Antonopoulos CN, Sergentanis TN, Papadopoulou C, et al. Uwar da ke shan taba a lokacin daukar ciki da lymphoma yara: a meta-bincike (link ne waje). Int J Cancer 2011; 129 (11): 2694-703.